SCHEMBL4407010

SCHEMBL4407010

Cc1ccc(-c2ccc(C)c(-c3cccc(-c4ccccn4)n3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.51
TP53 P04637 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
CCR1 P32246 3/20 0.51
CCR5 P51681 3/20 0.51
CCR8 P51685 3/20 0.51
LMNA P02545 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
ALPL P05186 1/20 0.51
HSP90AA1 P07900 1/20 0.51
ALPI P09923 1/20 0.51
ALPG P10696 1/20 0.51
ALOX15 P16050 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
GRM5 P41594 3/20 0.46
PKM P14618 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18571558 0.90 BTK (0.49) KDM4ETP53SMN1; SMN2CCR1CCR5
SCHEMBL4400289 0.89 MEN1 (0.39) KDM4ECCR1CCR8L3MBTL1TDP1
SCHEMBL4401772 0.88 KDM4E (0.58) KDM4ETP53SMN1; SMN2CCR1CCR5
SCHEMBL27085361 0.87 KDM4E (0.46) KDM4ETP53SMN1; SMN2CCR1CCR5
SCHEMBL17997027 0.86 MEN1 (0.40) KDM4ECCR1CCR8L3MBTL1TDP1
SCHEMBL1991759 0.84 KDM4E (0.56) KDM4ETP53SMN1; SMN2CCR1CCR5
SCHEMBL27085488 0.84 KDM4E (0.56) KDM4ETP53SMN1; SMN2CCR1CCR5
SCHEMBL4406997 0.83 TP53 (0.51) KDM4ETP53SMN1; SMN2CCR1CCR5
SCHEMBL18657149 0.82 NPC1 (0.46) KDM4ETP53SMN1; SMN2CCR1CCR5
SCHEMBL7963741 0.81 KDM4E (0.67) KDM4ETP53SMN1; SMN2CCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168307-B2 Organic compound, charge transport material and organic electroluminescent device PIONEER CORPORATION (JP) 2012-05-01 US disclosed
US-20090021146-A1 ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE PIONEER CORPORATION (JP) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090021146-A1 ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE SLC25A21, SLCO2A1, OCIAD2 KDM4E 2880/4885TP53 4235/4885SMN1; SMN2 2638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.